gvn
center
contrast
previou
gvn
meet
oral
present
relat
subject
block
session
arrang
seri
talk
cover
quit
divers
repertoir
issu
interest
virologist
around
world
criteria
select
award
includ
candid
publish
import
scientif
inform
virolog
area
interest
gvn
includ
limit
basic
scienc
clinic
aspect
pathogenesi
epidemiolog
diagnost
antivir
vaccin
develop
candid
made
consequenti
meaning
contribut
gvn
further
mission
gvn
includ
limit
develop
network
center
excel
particip
train
program
contribut
meet
gvn
activ
contribut
advocaci
public
commun
activ
robert
c
gallo
award
scientif
excel
leadership
award
dr
william
hall
gvn
cofound
scientif
present
scott
c
weaver
univers
texa
medic
branch
galveston
usa
gave
overview
histori
distribut
zika
viru
zikv
summar
recent
epidem
zikv
america
depict
associ
zikv
microcephali
establish
late
illustr
reaction
gvn
assembl
global
zika
task
forc
establish
within
three
month
associ
zikv
infect
microcephali
recogn
task
forc
gather
expert
flavivirus
arbovirus
viral
congenit
diseas
gvn
center
countri
besid
commun
latest
inform
zikv
distribut
expert
review
weaver
et
al
task
forc
support
privat
donat
establish
gvn
zikv
serum
bank
serum
bank
collect
character
sera
donor
expos
differ
countri
across
south
latin
america
made
collect
highli
character
sera
avail
intern
expert
lab
provid
lyophil
aliquot
provid
collect
zikv
strain
differ
viru
antigen
two
cdna
infecti
clone
weaver
also
report
zikv
vaccin
strain
attenu
delet
dnalaunch
zikv
liveattenu
vaccin
delet
mutant
viru
gave
rise
high
antibodi
titer
singl
immun
highli
protect
zikv
mous
model
well
rhesu
macaqu
infect
model
zou
et
al
busquet
centr
de
recerca
en
sanitat
anim
spain
highlight
import
arbovirus
pathogen
focus
surveil
vector
anim
reservoir
gave
short
overview
emerg
arbovirus
last
year
becom
import
global
public
health
threat
caus
signific
morbid
mortal
among
human
anim
chikungunya
dengu
zika
viru
carri
mosquito
easili
spread
also
arbovirus
eg
rift
valley
fever
viru
rvfv
west
nile
viru
wnv
critic
role
vertebr
host
anim
reservoir
dr
busquet
stress
good
surveil
data
base
intervent
strategi
thu
help
protect
public
health
save
money
thu
detail
knowledg
mosquito
speci
compet
host
viru
mosquito
present
well
vertebr
host
reservoir
presenc
import
knowledg
kinet
r
akkina
et
al
global
viru
network
wwwgvnorg
global
coalit
lead
virologist
found
notforprofit
organ
gvn
grown
center
excel
affili
institut
countri
throughout
world
gvn
mission
strengthen
research
respons
current
viral
caus
human
diseas
prepar
new
viral
pandem
threat
collabor
global
network
expert
virologist
gvn
activ
mainli
base
virolog
research
train
advocaci
gvn
intern
meet
one
way
support
mission
provid
framework
global
junior
senior
virologist
connect
discuss
establish
new
collabor
advanc
field
past
gvn
intern
meet
taken
place
washington
dc
usa
dublin
ireland
napl
itali
baltimor
md
usa
munich
germani
moscow
russia
beij
china
sapporo
japan
melbourn
australia
franc
gvn
intern
meet
took
place
barcelona
spain
june
jointli
organ
spanish
societi
virolog
meet
deleg
differ
countri
common
theme
throughout
meet
global
climat
chang
gvn
intern
meet
gave
particip
opportun
discuss
recent
find
virolog
thu
provid
platform
collabor
network
particularli
high
number
particip
young
spanish
virologist
confer
session
outlin
present
report
addit
plenari
lectur
workshop
held
sevgvn
joint
meet
contribut
format
short
oral
present
arrang
includ
wide
spectrum
issu
address
memberscientist
gvn
poster
session
allow
interest
discuss
among
essenti
younger
scientist
spanish
laboratori
particip
countri
perspect
first
time
gvn
establish
travel
grant
consist
partial
financi
help
encourag
particip
younger
member
http
receiv
octob
accept
novemb
infect
viremia
viru
shed
immun
respons
last
least
good
reliabl
rapid
diagnost
tool
point
viru
circul
vector
anim
reservoir
preced
human
exposur
infect
arboviru
outbreak
human
clinic
sign
might
detect
peak
outbreak
alreadi
pass
howev
viru
circul
vector
anim
reservoir
preced
human
infect
reusken
et
al
therefor
earli
detect
vector
anim
reservoir
host
serv
earli
warn
system
mitig
econom
human
health
impact
import
interplay
differ
inform
sourc
demonstr
combin
weather
forecast
syndrom
anim
surveil
el
nino
rain
kenya
result
effect
earli
warn
major
outbreak
rvfv
thu
allow
precaut
prevent
spill
human
oya
et
al
second
exampl
present
wnv
outbreak
american
contin
start
new
york
citi
cdc
emerg
wnv
lineag
spain
napp
et
al
case
dead
bird
surveil
identif
equin
infect
import
wnv
surveil
earli
warn
system
dr
busquet
conclud
arboviru
surveil
provid
realist
pictur
epidemiolog
situat
allow
monitor
effect
intervent
measur
surveil
vector
vertebr
host
enabl
detect
arboviru
circul
clinic
onset
human
howev
countri
need
adapt
surveil
scheme
epidemiolog
situat
surveil
object
capac
effect
earli
warn
requir
interact
multipl
disciplin
like
entomologist
veterinarian
biologist
clinician
epidemiologist
etc
masao
matsouka
kumamoto
univers
japan
gave
detail
insight
aspect
strategi
pathogenesi
human
tcell
leukemia
viru
type
present
focus
two
viral
protein
transactiv
viral
gene
express
tax
bzip
factor
hbz
causal
agent
adult
tcell
leukemia
atl
myelopathytrop
spastic
paraparesi
hamtsp
adult
close
rel
sever
nonhuman
primat
import
human
pathogen
global
distribut
infect
foci
estim
million
peopl
infect
sonoda
et
al
transmit
celltocel
contact
pass
viru
mother
infant
breast
milk
male
femal
semen
therefor
live
infect
cell
essenti
transmiss
order
enhanc
transmiss
viru
increas
number
infect
cell
cellular
receptor
ubiquit
manel
et
al
proviru
mainli
detect
effectormemori
cell
vivo
howev
clear
preferenti
infect
cell
infect
precursor
cell
differenti
cell
analyz
tax
express
marker
viral
replic
infect
japanes
macaqu
model
infect
human
matsouka
colleagu
show
elev
tax
express
mainli
seen
bone
marrow
suggest
de
novo
infect
hematopoiet
stem
cell
hsc
hamtsp
patient
detect
ident
integr
site
provirus
neutrophil
monocyt
b
cell
cell
cell
indic
cell
deriv
infect
hsc
vivo
tax
import
role
upregul
antiapoptot
gene
mainten
cell
popul
express
transient
like
tax
protein
highli
immunogen
major
target
ctl
leukem
cell
tax
express
minor
fraction
cell
short
period
time
mahgoub
et
al
matsouka
concentr
import
role
hbz
pathogenesi
hbz
encod
antisens
strand
proviru
low
immunogen
contrast
tax
express
constantli
atl
cell
hbz
regul
sever
differ
pathway
infect
cell
enabl
immun
escap
trigger
inflamm
induct
ifng
express
enabl
infect
overcom
immun
suppress
effect
hbz
also
induc
express
chemokin
receptor
allow
infiltr
infect
tcell
tissu
seen
transmit
celltocel
contact
suggest
hbzinduc
express
enabl
infect
cell
migrat
breast
milk
semen
thu
allow
effici
transmiss
viru
human
marion
koopman
erasmu
mc
netherland
elabor
present
complex
interplay
manmad
disturb
ecosystem
result
increas
number
amplitud
emerg
viral
diseas
outbreak
present
sever
exampl
underlin
chang
environment
condit
human
behavior
creat
condit
result
increas
pathogen
transmiss
spillov
new
host
broad
dissemin
infect
chang
viral
properti
recent
ebola
outbreak
west
africa
ongo
outbreak
democrat
republ
congo
illustr
demograph
polit
chang
affect
spread
diseas
dr
koopman
emphas
import
role
potenti
surveil
present
preliminari
result
arboviru
surveil
arbo
studi
data
influenza
market
surveil
poultri
china
bai
et
al
also
point
potenti
role
cocircul
differ
virus
eg
zika
dengu
new
pathogenesi
pathway
langerak
et
al
shift
burden
diseas
detect
clinician
earli
detect
forecast
spillov
surveil
reservoir
host
would
mean
paradigm
chang
surveil
emerg
infecti
diseas
reactiv
proactiv
measur
earli
detect
allow
time
control
thu
mitig
number
human
case
karesh
et
al
match
surveil
data
data
demograph
develop
global
travel
trade
climat
chang
might
allow
predict
potenti
intern
spread
pathogen
util
approach
much
depend
switch
detect
singl
pathogen
open
view
surveil
multiplex
assay
broad
antibodi
profil
metagenom
approach
effici
way
data
share
thoma
rasmussen
senior
research
nation
veterinari
institut
virolog
australia
present
updat
potenti
use
latencyrevers
agent
lra
hiv
elimin
great
success
antiretrovir
therapi
art
hiv
infect
temper
fact
treatment
must
maintain
life
rasmussen
review
work
show
hiv
remain
latent
state
immun
system
art
elimin
viru
rebound
viremia
occur
art
stop
even
individu
detect
viru
cell
plasma
experiment
approach
clear
latent
hiv
thu
cure
hiv
infect
dub
shock
kill
lra
use
activ
latent
hiv
allow
reactiv
cell
target
kill
art
andor
immun
system
administr
lra
alon
thu
far
demonstr
effect
frequenc
latent
infect
cell
time
viru
rebound
follow
interrupt
art
shock
kill
exampl
diorr
trial
dolutegravir
intensif
effect
residu
viru
replic
art
lead
rasmussen
chang
level
hiv
dna
rna
neg
result
mechan
failur
care
examin
import
demonstr
strategi
work
provid
guidanc
strategi
work
elimin
latent
infect
cell
particularli
longliv
may
requir
hivspecif
cell
effector
function
similar
socal
elit
control
infect
variou
strategi
boost
antihiv
immun
current
develop
includ
therapeut
vaccin
tolllik
receptor
agonist
broadli
neutral
antibodi
immun
checkpoint
inhibitor
interleukin
therapi
investig
immun
checkpoint
blockad
could
also
play
role
develop
hiv
cure
reinvigor
exhaust
cell
potenti
revers
hiv
latenc
cell
infect
mosquitoborn
virus
increas
past
decad
due
global
increas
societ
mobil
climat
chang
juana
diez
universitat
pompeu
fabra
love
host
citi
barcelona
continu
session
explor
virus
chikungunya
viru
chikv
abl
express
genom
high
level
cell
divers
speci
four
base
genet
code
creat
codon
translat
amino
acid
stop
codon
synonym
codon
differ
princip
third
base
wobbl
posit
differ
speci
includ
mosquito
human
vari
wide
codon
use
protein
translat
dr
diaz
team
integr
subcellular
fraction
transcriptomewid
analys
translat
human
cell
show
chikv
infect
induc
host
adapt
viral
codon
usag
endoplasm
reticulum
er
prefer
site
chikv
protein
express
trna
modif
enzym
methyltransferas
methyl
uridin
wobbl
posit
enhanc
speed
translat
certain
mrna
includ
chikv
mrna
mrna
translat
activ
chikv
infect
overexpress
increas
chikv
replic
mrna
silenc
decreas
replic
find
demonstr
unexpect
interplay
virus
host
trna
epitranscriptom
favor
viral
protein
express
mechan
appear
conserv
among
virus
replic
effect
singl
host
speci
open
intrigu
possibl
futur
exploit
broadspectrum
antivir
target
ebolavirus
caus
highli
lethal
diseas
sporad
unpredict
outbreak
ongo
outbreak
democrat
republ
congo
second
largest
histori
genom
ebola
viru
encod
seven
protein
deleteri
effect
human
bodi
immens
caus
sever
patholog
fatal
thu
basic
research
need
understand
viral
protein
conform
role
viral
replic
sara
lendera
bueno
scripp
research
institut
explain
sever
protein
multifunct
viral
cycl
also
multistructur
adopt
differ
form
differ
time
mediat
differ
essenti
function
use
crystallographi
electron
microscopi
biochemistri
found
two
essenti
protein
infect
nucleoprotein
np
matrix
protein
display
differ
conform
np
involv
viral
nucleocapsid
format
facilit
viral
transcript
replic
avoid
prematur
selfpolymer
nonproduct
bind
cellular
rna
np
chaperon
viral
phosphoprotein
np
complex
aminotermin
portion
delin
resolut
electron
microscopi
indic
import
bind
interact
control
np
polymer
structuredirect
mutagenesi
studi
identifi
conserv
critic
residu
interfac
could
target
broadli
effect
antivir
regard
matrix
protein
anoth
multistructur
protein
rearrang
three
altern
structur
correspond
function
differ
stage
life
cycl
structur
chang
trigger
remain
unclear
new
data
reveal
bind
dimer
specif
nucleotid
sequenc
enough
form
octamer
structureform
respons
regul
viral
rna
replic
find
provid
molecular
basi
multifunction
protein
reveal
attract
target
therapeut
intervent
kariem
ezzat
stockholm
univers
present
tantal
data
role
viral
protein
corona
viral
pathogenesi
amyloid
aggreg
virus
reli
intracellular
host
machineri
replic
product
viral
protein
assembl
howev
outsid
cell
virus
share
mani
biophys
properti
nanoparticl
base
featur
virus
capac
accumul
hostderiv
protein
corona
layer
extracellular
environ
similar
nanoparticl
evalu
possibl
implic
protein
corona
layer
respiratori
syncyti
viru
rsv
herp
simplex
viru
differ
biolog
fluid
human
plasma
bronchioalveolar
lavag
fluid
analyz
use
proteom
electron
microscopi
infect
dendrit
cell
activ
assay
found
rsv
accumul
rich
protein
corona
layer
uniqu
biolog
fluid
corona
precoat
differenti
affect
viral
infect
immun
cell
activ
addit
like
nanoparticl
virus
abl
function
nanosurfac
catalyst
enabl
acceler
extracellular
amyloid
protein
aggreg
author
also
show
implic
alzheim
diseas
catalyz
nucleat
accumul
peptid
vitro
vivo
result
ezzat
et
al
show
unlik
viral
genom
code
surfac
protein
viral
protein
corona
acquir
structur
layer
depend
viral
microenviron
result
differ
viral
ident
base
target
tissu
target
organ
addit
viral
coronadriven
heterogen
nucleat
amyloid
illustr
converg
viral
amyloid
patholog
suggest
direct
physic
mechanist
link
warrant
investig
ana
isabel
nunez
irtacresa
barcelona
spain
discuss
novel
find
mosquito
molecular
respons
arboviru
infect
particularli
relat
rift
valley
fever
phleboviru
rvfv
culex
pipien
literatur
aed
aegyptidengu
viru
denv
combin
studi
term
gene
express
howev
gener
pauciti
inform
mosquito
gene
involv
vector
compet
immun
respons
regard
import
vectorviru
interact
rvfv
caus
emerg
signific
public
health
zoonot
diseas
commonli
transmit
mainli
culex
aed
genu
mosquito
talk
molecular
respons
culex
pipien
rvfv
infect
present
particularli
relat
gene
implic
innat
immun
pathway
toll
imd
jakstat
rnai
total
differenti
express
gene
deg
identifi
gene
express
profil
vari
differ
day
post
infect
total
deg
found
wherein
deg
immun
function
relat
among
gene
involv
innat
immun
pathway
cactu
defensina
toll
pathway
drosha
rnai
pathway
specif
three
immun
pathway
toll
imd
rnai
apoptosi
affect
rvfv
infect
convers
jakstat
pathway
seem
involv
culex
pipien
respons
rvfv
toll
imd
pathway
suppress
infecti
blood
feed
exampl
amp
defensina
downregul
rnai
pathway
mainli
downregul
cours
rvfv
infect
immun
system
respons
would
allow
establish
rvfv
infect
culex
pipien
mosquito
result
form
basi
futur
depth
studi
better
understand
function
immun
relat
deg
relat
vector
compet
develop
new
strategi
vector
control
program
ken
olson
colorado
state
univers
review
rnai
arboviru
interact
infect
aed
aegypti
allow
transmiss
yellow
fever
dengu
zika
chikungunya
virus
throughout
mosquito
lifetim
mechan
viral
persist
mosquito
involv
product
viru
rnaderiv
sirna
pirna
well
understood
rna
interfer
pathway
involv
doubl
strand
rna
degrad
target
rna
mediat
gene
regul
studi
sirna
pirna
product
deplet
small
rna
sequenc
pirna
product
express
profil
immunoprecipit
arboviru
assay
use
dissect
viral
hostcel
interact
found
piwifamili
protein
antivir
activ
aed
aegypti
cell
mosquito
infect
arbovirus
insectspecif
flavivirus
although
rna
virus
encod
revers
transcriptas
circular
episom
dna
arbovirusinfect
aed
aegypti
cell
consist
hybrid
sequenc
arbovirusderiv
cdna
vdna
retrotranspos
element
found
episom
dna
appear
acquir
reversetranscript
discriminatori
process
vdna
recombin
retrotransposon
transcript
vdna
may
serv
precursor
antivir
vpirna
integr
viralderiv
vdna
also
detect
mosquito
genom
endogen
viral
element
eve
often
associ
pirna
cluster
mosquito
genom
eve
transcrib
produc
pirna
associ
preferenti
importantli
evederiv
pirna
inhibit
replic
cognat
viru
find
suggest
aed
aegypti
piwi
famili
protein
episom
vdna
eve
provid
mean
moder
viral
load
mosquito
cell
potenti
mechan
transgener
viru
toler
mosquito
richard
zhao
univers
maryland
present
data
virolog
differ
sever
histor
epidem
zika
virusmedi
infect
neurocytotox
zika
viru
zikv
outbreak
america
sever
impact
brazil
alon
left
babi
zikvassoci
neurolog
disord
zand
includ
microcephali
even
though
causal
relationship
zikv
zand
confirm
reason
zikv
suddenli
becam
pathogen
caus
zand
human
remain
larg
unknown
help
answer
question
virolog
differ
underli
molecular
mechan
repres
histor
african
zikv
strain
epidem
brazilian
zikv
strain
examin
glioma
cell
line
neurospher
use
evalu
primari
chimer
virus
notabl
differ
found
strain
regard
viral
attach
permiss
replic
well
induct
neurocytopath
effect
host
neuron
cell
chimer
viru
analys
suggest
zikv
e
protein
correl
viral
attach
cprm
region
contribut
permiss
zikvinduc
cytopath
effect
furthermor
prm
protein
cleav
pr
product
matur
protein
induc
apoptot
cell
death
cell
pr
region
resid
ntermin
side
prm
protein
respons
prminduc
apoptot
cell
death
mutat
analysi
identifi
four
aminoacid
residu
impact
abil
prm
induc
apoptosi
find
suggest
function
structur
prme
protein
contribut
part
differ
zikvmedi
viral
pathogen
histor
epidem
strain
ongo
studi
like
identifi
role
viral
protein
regard
neuropathogenesi
ramesh
akkina
colorado
state
univers
report
zikv
mediat
patholog
human
hematopoiet
cell
mani
previou
studi
focus
zikv
viral
effect
cn
explor
viral
effect
human
immun
hematopoiet
system
dr
akkina
present
vitro
vivo
studi
conduct
human
cell
vivo
studi
involv
human
mice
humic
harbor
transplant
human
immun
system
mice
gener
human
cell
b
cell
nk
cell
monocyt
macrophag
well
dendrit
cell
orchestr
humor
cellular
immun
respons
thu
ideal
model
examin
viral
effect
interact
human
immun
cell
akkina
sinc
humic
also
harbor
human
hematopoiet
stem
cell
bone
marrow
viral
effect
cell
also
ascertain
recent
studi
schmitt
et
al
shown
zikv
infect
humic
gener
human
neutral
antibodi
respons
zikv
also
human
b
cell
hsc
infect
studi
present
meet
investig
carri
zikv
infect
human
b
cell
vitro
vivo
determin
advers
effect
cell
death
cell
dysfunct
well
viral
persist
viral
exposur
matur
b
cell
result
loss
one
subset
aberr
prolifer
anoth
r
akkina
et
al
antivir
research
upregul
marker
indic
b
cell
progress
plasmablast
stage
seen
expand
subset
vivo
result
zikv
infect
humic
show
presenc
zikv
b
cell
peripheri
acut
infect
later
bone
marrow
chronic
stage
also
found
hsc
suscept
zikv
infect
vitro
could
detect
bone
marrow
infect
humic
b
cell
loss
lead
delay
viral
clearanc
wherea
aberr
b
cell
activ
may
implic
pathogenesi
autoimmun
diseas
syndrom
infect
hsc
implic
hematopoiet
cell
differenti
viral
persist
current
sever
murin
model
zikv
neuropathogenesi
exist
sinc
standard
mice
suscept
zikv
mostli
ifn
defici
mice
lack
innat
immun
system
thu
permit
readi
viral
infect
use
signific
drawback
model
viral
infect
lead
rapid
fatal
common
featur
zika
studi
present
balbc
mice
also
known
brg
mice
intact
ifn
pathway
use
neonat
mice
expos
zikv
develop
sever
microcephali
import
cz
featur
eye
deform
stunt
growth
model
like
use
experiment
neonat
zikv
infect
model
regard
human
cell
infect
find
highlight
util
humic
valuabl
human
surrog
experiment
system
directli
assess
zikv
effect
cell
vivo
christoph
kratochvil
codirector
global
center
health
secur
gch
univers
nebraska
present
mission
resourc
center
initi
univers
nebraska
medic
center
unmc
purpos
lead
us
domest
global
prepared
emerg
infecti
diseas
eid
http
wwwunmceduiexcelglobalcenterindexhtml
sinc
foundat
becom
primari
biosecur
resourc
train
educ
research
clinic
care
advanc
intern
capac
innov
prevent
mitig
effect
eid
public
health
emerg
program
success
built
upon
foundat
robust
partnership
divers
government
academ
organ
ktatochvil
et
al
eitzen
et
al
gch
numer
resourc
includ
clinic
biocontain
unit
quarantin
unit
train
simul
center
includ
simul
biocontain
unit
well
divers
laboratori
clinic
resourc
across
academ
health
center
strateg
health
organ
inform
laboratoryconfirm
human
case
includ
almost
fatal
ramadan
shaib
endem
middl
east
human
case
report
countri
symptom
rang
asymptomat
sever
pneumonia
acut
respiratori
distress
syndrom
ard
septic
shock
multiorgan
failur
vaccin
commerci
avail
specif
treatment
develop
dromedari
natur
reservoir
alpaca
also
report
potenti
host
merscov
chan
et
al
sinc
handl
dromedari
camel
easi
option
especi
biocointant
condit
base
preliminari
data
show
alpaca
valuabl
model
studi
earli
merscov
infect
event
catalan
scientist
set
develop
ex
vivo
model
deriv
latter
anim
dr
rodon
describ
isol
respiratori
tissu
assess
earli
local
immun
event
elicit
upon
infect
isol
nasal
mucosa
tracheal
explant
maintain
vitro
infect
merscovqatar
sampl
obtain
differ
time
h
postinocul
use
quantifi
viral
rna
rtqpcr
detect
viru
antigen
local
immunohistochemistri
ihc
isol
viru
work
indic
nasal
mucosa
tracheal
explant
alpaca
suitabl
ex
vivo
model
studi
merscov
replic
molecular
mechan
lead
viral
infect
andor
viru
clearanc
research
hope
develop
system
explor
antivir
therapeut
approach
stalin
raj
et
al
wendi
k
jo
riz
tiho
hannov
germani
describ
new
flaviviru
genu
pestiviru
detect
tooth
whale
north
sea
harbor
porpois
phocoena
phocoena
tautz
et
al
highthroughput
data
obtain
use
next
gener
sequenc
ng
analyz
use
inhous
metagenom
pipelin
follow
de
novo
assembl
phylogenet
analys
allow
identif
novel
pestiviru
two
three
investig
harbor
porpois
complet
genom
bp
reconstruct
de
novo
assembl
sequenc
read
confirm
sanger
sequenc
fulllength
genom
align
complet
genom
pestiviru
speci
show
newli
identifi
viru
evolutionari
closest
porcin
linda
viru
porcin
bungowannah
viru
homolog
amino
acid
level
situ
hybrid
show
strong
granular
stain
cytoplasm
multipl
cell
type
base
new
sequenc
inform
rtpcr
screen
sampl
strand
harbor
porpois
collect
north
sea
indic
anim
posit
novel
pestiviru
identif
novel
pestiviru
harbor
porpois
suggest
host
spectrum
pestivirus
extend
member
order
cetacea
whale
dolphin
porpois
consid
evolv
artiodactyl
evento
ungul
jo
et
al
elena
center
molecular
biolog
severo
ochoa
madrid
spain
report
outbreak
african
swine
fever
asf
affect
wild
boar
domest
pig
start
caucasu
spread
across
russia
eastern
europ
recent
geograph
expans
asf
increas
threat
global
swine
industri
karger
et
al
dr
present
inform
gene
involv
immun
evas
hypothet
involv
attenu
virul
genotyp
parent
asfv
base
inform
obtain
research
team
gener
put
live
attenu
vaccin
lav
prototyp
construct
recombin
virus
lack
specif
gene
contain
marker
diva
test
gallardo
et
al
bottleneck
product
live
attenu
viru
vaccin
lack
perman
cell
line
abl
sustain
product
viru
infect
studi
present
porcin
alveolar
macrophag
pam
use
propag
virus
result
show
natur
attenu
asfv
strain
induc
full
protect
homolog
genotyp
lisbon
heterolog
genotyp
ii
virul
strain
recombin
virus
carri
specif
delet
fulli
protect
parent
homolog
genotyp
lisbon
strain
slightli
protect
heterolog
genotyp
ii
circul
strain
studi
requir
assess
basi
lack
heterolog
protect
recombin
vaccin
strain
could
relat
cell
line
use
produc
vaccin
et
al
meagan
deme
institut
human
virolog
center
vaccin
develop
global
health
baltimor
unit
state
analyz
respons
hepat
b
vaccin
age
popul
depend
rout
inject
weinberg
et
al
william
et
al
de
lalla
et
al
fiftytwo
healthi
adult
year
mean
age
year
seroneg
hepat
b
hbv
recruit
enrol
senieur
protocol
select
strictli
healthi
popul
ligthart
et
al
senior
random
receiv
alumadjuv
recombin
hepb
vaccin
either
subcutan
sc
intramuscular
im
inject
inoculum
site
guid
computer
tomographi
ct
imag
immunolog
respons
express
antihb
antibodi
titer
day
demonstr
volunt
receiv
vaccin
im
threetim
like
respond
hbv
vaccin
volunt
receiv
sc
vaccin
versu
p
ikeno
et
al
low
seroconvers
rate
even
im
group
show
progress
declin
increas
age
cohort
associ
significantli
lower
isotyp
suggest
mark
shift
respons
moreov
percentag
senior
show
tcell
mediat
respons
significantli
reduc
also
lower
intens
compar
young
adult
arnold
et
al
studi
confirm
sc
inocul
site
markedli
impair
seroconvers
rate
probabl
relat
inocul
sc
fat
data
show
qualit
quantit
deficit
b
cell
respons
alum
adjuv
protein
antigen
even
strictli
healthi
elderli
cohort
schilli
et
al
abigail
low
univers
nebraska
medic
center
unit
state
turn
attent
institut
prepared
ethic
review
scenario
outbreak
clinic
research
epidem
crucial
build
urgent
respons
yet
requir
thought
oversight
research
ethic
committe
ensur
protect
vulner
subject
face
health
uncertainti
appropri
address
regulatori
aspect
cultiv
anticip
epidem
pandem
rather
respons
alirol
et
al
univers
nebraska
medic
center
unmc
institut
review
board
irb
respons
ebola
epidem
provid
exampl
research
ethic
review
rapid
respons
model
irb
provid
rapid
review
multipl
protocol
epidem
typic
h
less
submiss
approv
sinc
unmc
develop
central
irb
two
nation
network
focus
public
health
emerg
research
vision
establish
rapid
respons
resourc
network
busta
et
al
new
model
develop
adapt
research
network
order
pave
way
clinic
research
includ
earli
drug
develop
novel
pathogen
may
emerg
futur
outbreak
review
model
test
multisit
research
within
us
howev
also
need
explor
model
intern
public
health
emerg
research
process
complex
regulatori
well
oper
perspect
succeed
close
collabor
broad
stakehold
jordi
figuerola
de
csic
spain
albert
osterhau
research
center
emerg
infect
zoonos
riz
univers
veterinari
medicin
hannov
germani
amelia
nieto
centro
nacion
de
csic
spain
present
view
one
health
concept
take
account
field
wildlif
ecolog
well
veterinari
medic
infecti
diseas
disciplin
figuerola
highlight
fundament
contribut
wildlif
environ
includ
climat
chang
emerg
reemerg
zoonot
diseas
includ
exampl
mosquito
born
flavivirus
like
west
nile
viru
rizzoli
et
al
well
noninfecti
diseas
emphas
need
research
organ
interact
interact
environ
cornerston
understand
infecti
diseas
dynam
osterhau
cover
aspect
emerg
diseas
wildlif
livestock
companion
anim
role
play
emerg
human
infect
subsequ
highlight
need
priorit
syndrom
surveil
diagnost
platform
human
anim
well
increas
role
novel
molecular
technolog
pathogen
discoveri
kruppa
et
al
addit
stress
prioriti
must
coupl
platform
offer
mathemat
model
capac
anim
model
pathogenesi
studi
new
infect
moreov
aspect
accompani
invest
therapeut
discoveri
prevent
intervent
strategi
final
emphas
key
point
one
health
concept
commun
among
expert
politician
stakehold
societi
reper
et
al
nieto
focus
specif
one
devast
zoonos
human
histori
influenza
present
recent
result
show
heart
consid
new
target
influenza
virus
addit
lung
especi
strain
high
pathogen
addit
discuss
need
novel
develop
effect
ideal
univers
influenza
vaccin
well
effect
antivir
low
escap
potenti
present
roundtabl
open
deleg
sever
intervent
took
place
focus
issu
commun
contributor
agre
scientist
gener
best
advoc
commun
hazard
associ
emerg
reemerg
diseas
anim
human
alik
moreov
still
reactiv
framework
act
diseas
present
rather
move
toward
prevent
prepared
strategi
ideal
prevent
interspeci
transmiss
pathogen
occur
success
provid
tool
earli
detect
intervent
strategi
consequ
confront
emerg
epidem
sourc
onset
paramount
control
global
infecti
diseas
prevent
mitig
scenario
avail
adequ
resourc
peacetim
anoth
hot
topic
sinc
invest
prevent
prepared
scenario
done
prepar
emerg
infect
hous
fire
unfortun
nation
intern
level
current
realiti
show
gener
reactiv
rather
proactiv
willing
invest
prevent
prepared
scenario
titl
roundtabl
one
health
fact
fiction
intent
provoc
impact
deadli
infecti
diseas
far
differ
compar
develop
develop
countri
emphas
lack
global
coordin
effect
agenda
one
health
interestingli
concept
one
health
highlight
regularli
scientif
literatur
peerreview
articl
manuscript
propos
methodolog
measur
true
impact
implement
concept
moreov
suggest
quantit
indic
follow
common
methodolog
prove
avail
baum
et
al
therefor
conclud
roundtabl
discuss
much
effort
need
scientist
administr
politician
stakehold
citizen
truli
implement
one
health
concept
global
level
johan
neyt
rega
institut
medic
research
univers
leuven
belgium
start
session
give
overview
antivir
agent
avail
treatment
infect
hiv
hbv
hcv
influenza
rsv
infect
dr
neyt
point
mani
virus
caus
lifethreaten
infect
mani
consid
emerg
andor
neglect
pathogen
drug
avail
describ
robot
labinabox
autom
platform
environ
highthroughput
screen
instal
rega
institut
dr
neyt
present
current
state
rega
institut
develop
potent
antivir
flavivirus
dengu
alphavirus
chikungunya
enterovirus
well
norovirus
hepat
e
rabi
viru
sever
excel
molecular
target
select
inhibit
viral
replic
remain
larg
unexplor
identifi
nonstructur
protein
flavivirus
cap
machineri
alphavirus
helicas
enterovirus
rega
institut
molecul
target
dengu
viru
panserotyp
antivir
activ
low
nm
pm
rang
dr
neyt
also
report
antiflu
compound
favipiravir
also
activ
flavi
arena
bunya
filovirus
protect
mice
infect
chikungunya
viru
chikv
new
class
chikv
inhibitor
target
viral
cap
activ
low
microm
rang
also
describ
delang
et
al
gigant
et
al
enterorhinovirus
besid
target
capsid
binder
like
pocapavir
thibout
et
al
research
rega
institut
found
novel
druggabl
pocket
form
viral
protein
viru
capsid
identifi
analog
target
pocket
broad
spectrum
activ
abdelnabi
et
al
also
describ
novel
class
tryptophan
dendrim
target
capsid
fivefold
vertex
found
inhibit
replic
low
nanomolar
high
picomolar
concentr
vitro
sun
et
al
lead
compound
seri
prevent
bind
intern
viru
unlik
classic
capsid
binder
stabil
particl
dr
neyt
state
also
potent
inhibitor
enteroviru
viru
helicas
way
virus
antivir
substanc
test
rega
institut
includ
diarrhea
caus
virus
like
human
noroviru
zebra
fish
larva
found
replic
model
rota
viru
rabi
viru
hepat
e
viru
raymond
schinazi
emori
univers
school
medicin
present
recent
effort
develop
hbv
capsid
effector
may
offer
option
aid
combin
therapi
aim
cure
chronic
hepat
b
viru
hbv
infect
viru
affect
million
peopl
global
caus
death
worldwid
per
year
hbv
persist
due
format
covalentlyclos
circular
dna
cccdna
viral
minichromosomein
nucleu
hepatocyt
current
nucleosid
analog
interferon
therapi
low
rate
cccdna
clearanc
requir
lifelong
treatment
schinazi
et
al
schinazi
asselah
boucl
et
al
dr
schinazi
group
identifi
compound
novel
potenti
bestinclass
glyoxamid
deriv
affect
hbv
nucleocapsid
format
replenish
cccdna
pool
drug
ec
low
nm
rang
therapeut
index
human
mous
model
stabli
engraft
human
hepatocyt
infect
hbv
display
major
effect
hbeag
secret
hbsag
addit
promis
preclin
profil
interestingli
long
term
combin
treatment
entecavir
etv
model
induc
four
log
decreas
viral
load
viral
antigen
reduct
sustain
week
ceas
treatment
dr
schinazi
also
briefli
describ
activ
novel
noroviru
proteas
inhibitor
also
interestingli
effect
certain
enterovirus
nm
level
enteroviru
proteas
similar
noroviru
coxsackieviru
proteas
instituto
de
iqm
consejo
superior
de
investigacion
csic
spain
argu
antivir
drug
develop
particular
characterist
compar
therapeut
field
drug
discoveri
exampl
indic
phenotyp
screen
still
one
main
strategi
identifi
novel
class
antivir
agent
therapeut
area
targetbas
fragmentbas
screen
often
becom
relev
murcko
j
brown
bostrom
hit
antivir
properti
identifi
optim
becom
lead
multiparamet
process
also
determin
mechan
action
compound
dr
group
experi
triazolopyrimidin
inhibitor
chikv
replic
present
illustr
proactiv
collabor
effort
among
academ
group
lead
identif
optim
antivir
explor
new
mechan
action
gigant
et
al
delang
et
al
gigant
et
al
gomez
sanjuan
et
al
esteban
domingo
centro
de
molecular
severo
ochoa
csicuam
spain
discuss
develop
antivir
resist
evolut
virus
involv
two
major
step
intrahost
shortterm
ii
interhost
longterm
evolut
step
influenc
mainli
random
genom
variat
quasispeci
dynam
descript
base
mutant
spectrum
analys
step
ii
guid
multifactori
epidemiolog
fit
transmissionassoci
random
drift
genom
descript
base
phylodynam
approach
geoghegan
holm
domingo
peral
event
step
influenc
event
step
ii
open
question
select
mutant
resist
antivir
agent
one
major
problem
antivir
therapi
occur
step
consequ
felt
step
ii
sever
mechan
select
mutant
resist
antivir
agent
identifi
includ
amino
acid
substitut
term
ra
resistanceassoci
substitut
viral
protein
target
antivir
agent
antivir
resist
mediat
high
viral
fit
document
hepat
c
viru
hcv
mechan
affect
standard
inhibitor
mutagen
agent
activ
lethal
mutagenesi
intrahost
select
resist
mutant
affect
treatment
efficaci
choic
rescu
treatment
resist
mutant
acquir
epidemiolog
relev
therefor
affect
step
ii
viru
evolut
epidemiolog
domin
resist
mutant
may
render
ineffect
relev
antivir
agent
problem
similar
antibiot
resist
bacteria
possibl
approach
minim
select
escap
mutant
inspir
quasispeci
dynam
suggest
leo
poon
univers
hong
kong
review
emerg
influenza
virus
like
circul
southeastern
china
virus
continu
reassort
differ
avian
influenza
virus
spread
geograph
locat
via
wild
bird
dr
poon
report
studi
low
pathogen
avian
influenza
viru
genom
detect
wild
bird
sampl
collect
phylogeograph
analysi
indic
sever
independ
transregion
reassort
event
period
reassort
virus
acquir
least
one
segment
avian
influenza
virus
found
northsouth
america
yungme
jee
nation
institut
health
south
korea
report
middl
east
respiratori
syndrom
coronaviru
merscov
outbreak
south
korea
emphas
lesson
learn
experi
follow
singl
miss
case
may
trigger
huge
nationwid
outbreak
first
line
defens
thermal
scanner
airport
doctor
commun
clinicshospit
superspread
event
may
occur
healthcar
set
especi
emerg
depart
earli
detect
isol
critic
import
aggress
strategi
quarantin
mayb
necessari
especi
larg
number
individu
expos
healthcar
set
enric
mateu
depart
de
sanitat
anatoia
anim
universitat
autonoma
de
barcelona
spain
describ
virul
immun
porcin
reproduct
respiratori
syndrom
viru
prrsv
two
side
problem
emphas
genet
basi
differ
virul
multigen
relat
damag
caus
viru
ii
damag
caus
immun
respons
pig
iii
interact
viru
function
immun
system
neutral
antibodi
cellmedi
immun
abil
disabl
induc
type
interferon
macrophag
plasmacytoid
dendrit
cell
make
complex
diseas
outcom
influenza
surveil
cameroon
monitor
hepat
b
viru
rural
district
india
viru
evolut
threedimension
cell
cultur
infect
model
new
target
antivir
intervent
dr
richard
njouom
centr
pasteur
cameroon
yaound
cameroon
show
data
influenza
surveil
cameroon
last
year
although
influenza
viru
strain
circul
countri
year
round
larger
preval
observ
raini
season
major
peak
septemb
decemb
type
influenza
b
detect
everi
year
although
strain
preval
data
consid
unfortun
surveil
system
reveal
mani
season
influenza
vaccin
composit
avail
good
match
type
subtyp
circul
cameroon
dr
shyam
kottilil
institut
human
virolog
univers
maryland
baltimor
usa
present
impress
effort
monitor
hepat
b
viru
hbv
western
district
arunach
pradesh
india
part
gvnlead
program
research
interview
patient
collect
sampl
hbv
test
found
high
hbv
seropreval
studi
commun
particularli
nyishi
miji
tribe
interest
observ
abund
cd
recombin
genotyp
previous
found
neighbor
tibet
probabl
consequ
migrat
across
chines
border
two
studi
viru
evolut
present
dr
dieter
hoffmann
technisch
munich
germani
richard
scheuermann
j
craig
venter
institut
la
jolla
usa
dr
hoffmann
colleagu
studi
noroviru
evolut
chronic
infect
patient
use
nextgener
sequenc
previous
shown
noroviru
capsid
gene
sequenc
evolv
quickli
accumul
nonsynonym
mutat
reflect
posit
select
hoffmann
et
al
sequenti
appear
mutat
correl
structur
chang
may
lead
decreas
antibodi
bind
interestingli
dr
hoffman
group
report
infect
individu
progress
infect
associ
increas
concentr
capsidspecif
antibodi
present
dr
scheuermann
concentr
enteroviru
evolut
enteroviru
ev
outbreak
summer
coincid
spike
number
case
poliolik
acut
flaccid
myelitisparalysi
afm
subsequ
outbreak
rais
concern
possibl
ev
new
public
health
threat
compar
genom
analysi
show
emerg
new
ev
lineag
recent
year
cell
cultur
anim
studi
reveal
emerg
virus
acquir
abil
infect
kill
neuron
cell
caus
paralysi
mice
virion
bind
cell
entri
limit
neuron
infect
older
isol
basic
research
repres
work
dr
heinz
ellerbrok
robert
koch
institut
berlin
germani
develop
new
threedimension
cell
cultur
infect
model
base
biolog
extracellular
matrix
decellular
equin
pericardium
primari
human
keratinocyt
koban
et
al
use
model
studi
antivir
suscept
cowpox
viru
infect
ellerbrok
colleagu
show
inhibitori
potenc
hostdirect
epiderm
growth
factor
receptorblock
molecul
gefitinib
cetuximab
consider
higher
threedimension
cell
cultur
model
convent
twodimension
model
suggest
classic
monolay
cell
cultur
could
underestim
potenti
inhibitori
effect
undetermin
number
antivir
drug
dr
lui
centro
de
molecular
severo
ochoa
madrid
spain
present
new
data
revers
transcriptas
rt
connect
subdomain
mutat
nonnucleosid
rt
inhibitor
modul
polypurin
tract
ppt
remov
initi
plusstrand
dna
synthesi
betancor
et
al
use
differ
rt
variant
studi
show
major
determin
defin
correct
cleavag
site
junction
hiv
genom
resid
connect
subdomain
posit
observ
togeth
fact
nevirapin
doravirin
efavirenz
alter
effici
cleavag
impair
initi
strand
dna
synthesi
suggest
step
revers
transcript
could
becom
specif
target
antiretrovir
intervent
gvn
short
cours
took
place
baltimor
juli
train
date
total
junior
scientist
everi
contin
gvn
current
develop
gvn
academi
initi
invest
small
group
outstand
midcar
virologist
pilot
program
idea
match
select
number
outstand
earli
midcar
lowandmiddleincom
countri
virolog
research
senior
leader
field
provid
seri
mentor
network
opportun
gvn
also
work
develop
region
gvn
chapter
shift
toward
flexibl
global
organ
although
gvn
headquart
baltimor
believ
gvn
presenc
need
truli
global
therefor
gvn
center
need
meet
specif
geograph
challeng
found
particularli
southeast
asia
south
america
africa
year
gvn
establish
africa
gvn
region
unit
meet
coorgan
dr
pontiano
kaleebu
director
uvri
dr
glenda
gray
presid
mrc
south
africa
meet
took
place
entebb
uganda
help
delin
collabor
well
plan
futur
joint
train
initi
gvn
continu
provid
public
educ
expert
perspect
current
topic
ebola
outbreak
drc
anticip
prepared
task
forc
umbrella
sever
viru
watch
group
establish
meet
regularli
discuss
recent
advanc
find
field
monitor
virus
viru
research
ensur
efficaci
reinforc
gvn
capac
process
organ
gvn
intern
meet
medellin
colombia
uniqu
opportun
increas
collabor
south
american
region
gvn
gvn
center
part
globe
plan
underway
south
east
asia
region
gvn
kickoff
meet
effort
lead
dr
sharon
lewin
linfa
wang
gvn
continu
foster
collabor
among
member
exampl
joint
grant
applic
implement
variou
activ
anticip
prepared
task
forc
well
viru
watch
group
